Interleukin-33 in tumorigenesis, tumor immune evasion, and cancer immunotherapy
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interleukin-33 in tumorigenesis, tumor immune evasion, and cancer immunotherapy
Authors
Keywords
Interleukin-33, Tumorigenesis, Cancer immunotherapy, CD8 T cell, MDSC
Journal
JOURNAL OF MOLECULAR MEDICINE-JMM
Volume 94, Issue 5, Pages 535-543
Publisher
Springer Nature
Online
2016-02-27
DOI
10.1007/s00109-016-1397-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The IL-33/ST2 axis augments effector T-cell responses during acute GVHD
- (2015) D. K. Reichenbach et al. BLOOD
- A Distinct Function of Regulatory T Cells in Tissue Protection
- (2015) Nicholas Arpaia et al. CELL
- Antigen- and Cytokine-Driven Accumulation of Regulatory T Cells in Visceral Adipose Tissue of Lean Mice
- (2015) Dmitriy Kolodin et al. Cell Metabolism
- IL-33 facilitates oncogene-induced cholangiocarcinoma in mice by an interleukin-6-sensitive mechanism
- (2015) Daisaku Yamada et al. HEPATOLOGY
- Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation
- (2015) Ari B. Molofsky et al. IMMUNITY
- Liver-Resident Macrophage Necroptosis Orchestrates Type 1 Microbicidal Inflammation and Type-2-Mediated Tissue Repair during Bacterial Infection
- (2015) Camille Blériot et al. IMMUNITY
- Interleukin-33 and Interferon-γ Counter-Regulate Group 2 Innate Lymphoid Cell Activation during Immune Perturbation
- (2015) Ari B. Molofsky et al. IMMUNITY
- IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms
- (2015) Lukas F. Mager et al. JOURNAL OF CLINICAL INVESTIGATION
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
- (2015) Stefani Spranger et al. NATURE
- The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue–resident regulatory T cells
- (2015) Ajithkumar Vasanthakumar et al. NATURE IMMUNOLOGY
- Inflammation and cancer: advances and new agents
- (2015) Shanthini M. Crusz et al. Nature Reviews Clinical Oncology
- Increased Serum Levels of the IL-33 Neutralizing sST2 in Limited Cutaneous Systemic Sclerosis
- (2015) A. Wagner et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Interleukin 33 in tumor microenvironment is crucial for the accumulation and function of myeloid-derived suppressor cells
- (2015) Peng Xiao et al. OncoImmunology
- The role of IL-33 and mast cells in allergy and inflammation
- (2015) Rohit Saluja et al. Clinical and Translational Allergy
- Expression of interleukin-33 is correlated with poor prognosis of patients with squamous cell carcinoma of the tongue
- (2014) Kazuya Ishikawa et al. AURIS NASUS LARYNX
- Oncogenic Kras Activates a Hematopoietic-to-Epithelial IL-17 Signaling Axis in Preinvasive Pancreatic Neoplasia
- (2014) Florencia McAllister et al. CANCER CELL
- Alarmin IL-33 Acts as an Immunoadjuvant to Enhance Antigen-Specific Tumor Immunity
- (2014) Daniel O. Villarreal et al. CANCER RESEARCH
- RIPK1 Regulates RIPK3-MLKL-Driven Systemic Inflammation and Emergency Hematopoiesis
- (2014) James A. Rickard et al. CELL
- Serum amyloid A induces interleukin-33 expression through an IRF7-dependent pathway
- (2014) Lei Sun et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Altered subcellular localization of IL-33 leads to non-resolving lethal inflammation
- (2014) Juliana Bessa et al. JOURNAL OF AUTOIMMUNITY
- Biliary repair and carcinogenesis are mediated by IL-33–dependent cholangiocyte proliferation
- (2014) Jun Li et al. JOURNAL OF CLINICAL INVESTIGATION
- Tumoral Expression of IL-33 Inhibits Tumor Growth and Modifies the Tumor Microenvironment through CD8+T and NK Cells
- (2014) Xin Gao et al. JOURNAL OF IMMUNOLOGY
- IL-33 Is an Unconventional Alarmin That Stimulates IL-2 Secretion by Dendritic Cells To Selectively Expand IL-33R/ST2+Regulatory T Cells
- (2014) Benjamin M. Matta et al. JOURNAL OF IMMUNOLOGY
- Examining IL-33 expression in the cervix of HPV-infected patients: a preliminary study comparing IL-33 levels in different stages of disease and analyzing its potential association with IFN-γ
- (2014) Lei Wang et al. MEDICAL ONCOLOGY
- The alarmin IL-33 promotes regulatory T-cell function in the intestine
- (2014) Chris Schiering et al. NATURE
- Interleukin-33/ST2 axis promotes epithelial cell transformation and breast tumorigenesis via upregulation of COT activity
- (2014) J Y Kim et al. ONCOGENE
- Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells
- (2014) E. Lefrancais et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High Serum Levels of the Interleukin-33 Receptor Soluble ST2 as a Negative Prognostic Factor in Hepatocellular Carcinoma
- (2014) Dominik Bergis et al. Translational Oncology
- Interleukin-33 Potentiates Bleomycin-Induced Lung Injury
- (2013) Irina G. Luzina et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Serum IL-33 as a Diagnostic and Prognostic Marker in Non-small Cell Lung Cancer
- (2013) Liang-An Hu et al. Asian Pacific Journal of Cancer Prevention
- Transgenic expression of IL-33 activates CD8+ T cells and NK cells and inhibits tumor growth and metastasis in mice
- (2013) Kun Gao et al. CANCER LETTERS
- Interleukin-33-Dependent Innate Lymphoid Cells Mediate Hepatic Fibrosis
- (2013) Tamar Mchedlidze et al. IMMUNITY
- The Interleukin-1 Family: Back to the Future
- (2013) Cecilia Garlanda et al. IMMUNITY
- Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells
- (2013) Ivan P. Jovanovic et al. INTERNATIONAL JOURNAL OF CANCER
- The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma
- (2013) Su-Feng Chen et al. JOURNAL OF PATHOLOGY
- IL-33 accelerates cutaneous wound healing involved in upregulation of alternatively activated macrophages
- (2013) Hui Yin et al. MOLECULAR IMMUNOLOGY
- ST2 as a Marker for Risk of Therapy-Resistant Graft-versus-Host Disease and Death
- (2013) Mark T. Vander Lugt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Higher numbers of T-bet+ intratumoral lymphoid cells correlate with better survival in gastric cancer
- (2012) Lu-jun Chen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- IL-33 citrine reporter mice reveal the temporal and spatial expression of IL-33 during allergic lung inflammation
- (2012) Clare S. Hardman et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Transcriptional Regulation of Murine IL-33 by TLR and Non-TLR Agonists
- (2012) S. K. Polumuri et al. JOURNAL OF IMMUNOLOGY
- Novel Splice Variants of IL-33: Differential Expression in Normal and Transformed Cells
- (2012) Hidetoshi Tsuda et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic Significance and Gene Expression Profiles of p53 Mutations in Microsatellite-Stable Stage III Colorectal Adenocarcinomas
- (2012) Venkat R. Katkoori et al. PLoS One
- Presensitizing with a Toll-like receptor 3 ligand impairs CD8 T-cell effector differentiation and IL-33 responsiveness
- (2012) S. M. Ngoi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G
- (2012) E. Lefrancais et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Alarmin Interleukin-33 Drives Protective Antiviral CD8+ T Cell Responses
- (2012) W. V. Bonilla et al. SCIENCE
- Involvement of the TGF-β and β-Catenin Pathways in Pelvic Lymph Node Metastasis in Early-Stage Cervical Cancer
- (2011) Maartje G. Noordhuis et al. CLINICAL CANCER RESEARCH
- Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis
- (2011) Koichi Yanaba et al. CLINICAL RHEUMATOLOGY
- IL-33 Expands Suppressive CD11b+ Gr-1int and Regulatory T Cells, including ST2L+ Foxp3+ Cells, and Mediates Regulatory T Cell-Dependent Promotion of Cardiac Allograft Survival
- (2011) H. R. Turnquist et al. JOURNAL OF IMMUNOLOGY
- Identification of early molecular markers for breast cancer
- (2011) Céline Kretschmer et al. Molecular Cancer
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-33 prolongs allograft survival during chronic cardiac rejection
- (2011) Stefan M. Brunner et al. TRANSPLANT INTERNATIONAL
- Inflammatory Bowel Disease-Associated Interleukin-33 Is Preferentially Expressed in Ulceration-Associated Myofibroblasts
- (2010) Jon Sponheim et al. AMERICAN JOURNAL OF PATHOLOGY
- Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts
- (2010) S. P. Kerkar et al. CANCER RESEARCH
- A natural protective function of invariant NKT cells in a mouse model of innate-cell-driven lung inflammation
- (2010) Elvire A. Bourgeois et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis
- (2010) Ayako Kobori et al. JOURNAL OF GASTROENTEROLOGY
- T-bet and Eomesodermin Are Required for T Cell-Mediated Antitumor Immune Responses
- (2010) Y. Zhu et al. JOURNAL OF IMMUNOLOGY
- Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity
- (2010) Daniel R. Neill et al. NATURE
- Systemically dispersed innate IL-13-expressing cells in type 2 immunity
- (2010) A. E. Price et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis
- (2009) Gaby Palmer et al. ARTHRITIS AND RHEUMATISM
- Targeting Inflammatory Pathways for Prevention and Therapy of Cancer: Short-Term Friend, Long-Term Foe
- (2009) B. B. Aggarwal et al. CLINICAL CANCER RESEARCH
- The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-γ production
- (2009) Elvire Bourgeois et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Suppression of Interleukin-33 Bioactivity through Proteolysis by Apoptotic Caspases
- (2009) Alexander U. Lüthi et al. IMMUNITY
- IL-33 Induces IL-13-Dependent Cutaneous Fibrosis
- (2009) A. L. Rankin et al. JOURNAL OF IMMUNOLOGY
- Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells
- (2009) Kazuyo Moro et al. NATURE
- The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1
- (2009) C. Cayrol et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A–H2B acidic pocket
- (2008) Lucie Roussel et al. EMBO REPORTS
- IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK Cells
- (2008) M. D. Smithgall et al. INTERNATIONAL IMMUNOLOGY
- Inflammation: Gearing the journey to cancer
- (2008) J KUNDU et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- The IL-1-Like Cytokine IL-33 Is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells In Vivo: A Novel ‘Alarmin’?
- (2008) Christine Moussion et al. PLoS One
- Cellular and molecular mechanisms of fibrosis
- (2007) TA Wynn JOURNAL OF PATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More